BACKGROUND
Programmed cell death factor 4 (PDCD4) has been implicated in various metabolic disorders. However, its role and underlying mechanisms in metabolic dysfunction-associated steatotic liver disease (MASLD) have not been fully elucidated.
PURPOSE
This study aimed to define the role of PDCD4 in hepatic steatosi...
Xiao-Na Cheng, Kai-Kai Lu, Lu-Yun Yang et al.· Phytomedicine· 0 citations
A higher CKM stage is associated with an increased long-term risk of MACEs and LREs across the SLD spectrum, and obesity and hypertension are the primary contributors to both outcomes, and diabetes additionally contributes to LREs.
Qiong-Yue Fan, Li-You Lian, Tian-Yi Xia et al.· i Medicina· 0 citations
This study identifies KIF13B as a novel regulator of hepatic lipid homeostasis in ALD via the KIF13B-KPNA2-PPARα axis, enhancing KPNA2 mediated nuclear import, particularly in combination with PPARα activation, represents a promising therapeutic strategy for ALD.
Kai-Kai Lu, Si Mei, Lian-Xing Zhang et al.· Gut· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.